PREVIOUS
✖
Chennai BCG Vaccine Centre Reopens
October 17 , 2019
1855 days
1257
0
- After 11 years, Chennai-based BCG Vaccine Laboratory has got back Union government’s permission to restart mass production of anti-tuberculosis vaccine for commercial use.
- It has reopened after adhering to the Good Manufacturing Practices (GMP) Protocol.
- The lab plans to roll out least 300 lakh doses required for the universal immunization programme, by 2021.
- Scientists in the lab use a strain from Mycobacterium bovis BCG strain.
- It can supply TB Vaccines at much lower prices than private players.
- The laboratory was established in 1948 with the assistance of Statens Serum Institut (SSI) Copenhagen, Denmark and World Health Organization (WHO).
Leave a Reply
Your Comment is awaiting moderation.